company background image
MEDPLUS logo

MedPlus Health Services NSEI:MEDPLUS Stock Report

Last Price

₹697.25

Market Cap

₹83.4b

7D

-0.9%

1Y

-12.7%

Updated

15 Jun, 2024

Data

Company Financials +

MedPlus Health Services Limited

NSEI:MEDPLUS Stock Report

Market Cap: ₹83.4b

MEDPLUS Stock Overview

Engages in the retail trading of medicines and general items in India.

MEDPLUS fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance5/6
Financial Health6/6
Dividends0/6

MedPlus Health Services Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MedPlus Health Services
Historical stock prices
Current Share Price₹697.25
52 Week High₹978.00
52 Week Low₹598.60
Beta0.87
1 Month Change-0.99%
3 Month Change4.76%
1 Year Change-12.72%
3 Year Changen/a
5 Year Changen/a
Change since IPO-37.81%

Recent News & Updates

Recent updates

Is Now The Time To Put MedPlus Health Services (NSE:MEDPLUS) On Your Watchlist?

Feb 03
Is Now The Time To Put MedPlus Health Services (NSE:MEDPLUS) On Your Watchlist?

MedPlus Health Services (NSE:MEDPLUS) Will Want To Turn Around Its Return Trends

Dec 11
MedPlus Health Services (NSE:MEDPLUS) Will Want To Turn Around Its Return Trends

A Look At The Intrinsic Value Of MedPlus Health Services Limited (NSE:MEDPLUS)

Oct 24
A Look At The Intrinsic Value Of MedPlus Health Services Limited (NSE:MEDPLUS)

The Returns On Capital At MedPlus Health Services (NSE:MEDPLUS) Don't Inspire Confidence

Jul 18
The Returns On Capital At MedPlus Health Services (NSE:MEDPLUS) Don't Inspire Confidence

Why Investors Shouldn't Be Surprised By MedPlus Health Services Limited's (NSE:MEDPLUS) P/S

Jun 22
Why Investors Shouldn't Be Surprised By MedPlus Health Services Limited's (NSE:MEDPLUS) P/S

A Look At The Fair Value Of MedPlus Health Services Limited (NSE:MEDPLUS)

Apr 18
A Look At The Fair Value Of MedPlus Health Services Limited (NSE:MEDPLUS)

MedPlus Health Services (NSE:MEDPLUS) Could Be Struggling To Allocate Capital

Feb 08
MedPlus Health Services (NSE:MEDPLUS) Could Be Struggling To Allocate Capital

₹1,177: That's What Analysts Think MedPlus Health Services Limited (NSE:MEDPLUS) Is Worth After Its Latest Results

Jun 03
₹1,177: That's What Analysts Think MedPlus Health Services Limited (NSE:MEDPLUS) Is Worth After Its Latest Results

Shareholder Returns

MEDPLUSIN Consumer RetailingIN Market
7D-0.9%0.009%2.7%
1Y-12.7%15.6%44.9%

Return vs Industry: MEDPLUS underperformed the Indian Consumer Retailing industry which returned 15.6% over the past year.

Return vs Market: MEDPLUS underperformed the Indian Market which returned 44.9% over the past year.

Price Volatility

Is MEDPLUS's price volatile compared to industry and market?
MEDPLUS volatility
MEDPLUS Average Weekly Movement3.1%
Consumer Retailing Industry Average Movement5.3%
Market Average Movement6.5%
10% most volatile stocks in IN Market9.5%
10% least volatile stocks in IN Market4.3%

Stable Share Price: MEDPLUS has not had significant price volatility in the past 3 months.

Volatility Over Time: MEDPLUS's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200619,626Madhukar Gangadiwww.medplusindia.com

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits; and offers fast-moving consumer goods, such as toiletries, baby care products, soaps, detergents, and sanitizers. The company also provides wholesale cash and carry, and pathological laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals.

MedPlus Health Services Limited Fundamentals Summary

How do MedPlus Health Services's earnings and revenue compare to its market cap?
MEDPLUS fundamental statistics
Market cap₹83.35b
Earnings (TTM)₹654.73m
Revenue (TTM)₹56.25b

127.3x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MEDPLUS income statement (TTM)
Revenue₹56.25b
Cost of Revenue₹43.92b
Gross Profit₹12.33b
Other Expenses₹11.68b
Earnings₹654.73m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)5.48
Gross Margin21.92%
Net Profit Margin1.16%
Debt/Equity Ratio0%

How did MEDPLUS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.